Perry A. Karsen

Insider Reports History

Location
C/O Celgene Corporation, 86 Morris Avenue, Summit, NJ
Signature
/s/ Zed Zduniak, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Perry A. Karsen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Graphite Bio, Inc. Director Stock Option (right to buy) 20K Jul 19, 2023 Direct
Jounce Therapeutics, Inc. Director Common Stock 0 $1.85 May 3, 2023 Direct
Jounce Therapeutics, Inc. Director Stock Option (Right to Buy) 0 May 3, 2023 Direct

Insider Reports Filed by Perry A. Karsen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GRPH Graphite Bio, Inc. Jul 19, 2023 1 $0 4 Jul 21, 2023 Director
JNCE Jounce Therapeutics, Inc. May 3, 2023 8 $0 4 May 4, 2023 Director
JNCE Jounce Therapeutics, Inc. Jun 24, 2022 1 $0 4 Jun 28, 2022 Director
GRPH Graphite Bio, Inc. Jun 21, 2022 1 $0 4 Jun 22, 2022 Director
GRPH Graphite Bio, Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 Director
JNCE Jounce Therapeutics, Inc. Jun 18, 2021 1 $0 4 Jun 22, 2021 Director
GRPH Graphite Bio, Inc. Jan 13, 2021 5 $100K 4 Jul 1, 2021 Director